GA
BHC icon

Geneva Advisors’s Bausch Health BHC Stock Holding History

Geneva Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,050
Closed -$233K – 650
2015
Q2 		$233K Sell
1,050
-50
-5% -$11.1K ﹤0.01% 576
2015
Q1 		$218K Buy
+1,100
New +$195K ﹤0.01% 580

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geneva Advisors's BHC Position: Q3 2015 in Review

Geneva Advisors sold out of Bausch Health (BHC) in Q3 2015, closing a stake of 1,050 shares — an estimated $233K sold.

Geneva Advisors first reported a position in BHC in Q1 2015 and held it in 2 quarters. The position peaked at $233K in Q2 2015. 546 funds tracked by Wall St. Rank hold BHC as of Q3 2015.

  • Geneva Advisors reported no remaining Bausch Health position as of Q3 2015 after selling out during the quarter.
  • Geneva Advisors sold 1,050 Bausch Health shares in Q3 2015, an estimated $233K.
  • Geneva Advisors first reported a position in Bausch Health in Q1 2015 and held it in 2 quarters.
  • Geneva Advisors's Bausch Health position peaked at $233K in Q2 2015.
  • 546 funds tracked by Wall St. Rank held Bausch Health as of Q3 2015.

Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.